Life Sciences - Health Care - Emerging Markets

Protecting and promoting life sciences in emerging markets
Innovation plays an essential role in addressing global health care needs. In an effort to increase innovation capacity and reduce development time and cost, life sciences firms are turning to emerging markets as a source of research, development and production capabilities. A new Deloitte Research brief looks at the opportunities and challenges in these markets.

BIO2008 Annual International Convention
Learn about Deloitte's involvement at the Biotechnology Industry Organization's Annual Convention to be held June 17-20, 2008 in San Diego, CA, USA.

Life Sciences and Health Care Industry alerts
Sign up to receive email alerts from Deloitte Research.

Health Care Webcasts
Deloitte professionals discuss key Life Sciences and Health Care issues in the Dbriefs Webcasts series.

	Email us about Life Sciences and Health Care
	Submit request for proposal
	Locate a Deloitte member firm

Life sciences companies are facing increasing pressure to produce innovative treatments and cures while meeting financial objectives. While doing business in emerging markets has the potential for significant cost savings and new revenue streams, there are pitfalls. Regardless of their location, life sciences companies are likely to face a great deal of upheaval as they strive to reinvent their strategies to achieve success.

The professionals at Deloitte member firms understand the challenges facing the Life Sciences and Health Care industry. Contact us to learn more and be sure to read the related research and reports on this page.

The right spice The Indian pharmaceutical market is big and getting bigger, but this growth has been accompanied by uncertainty around the future of the regulatory environment, among other factors.	Managing convergence Life sciences firms are moving beyond traditional industry boundaries to create new health care solutions for patients and providers.
Strategies for success in 2015 Acquisitions, mergers and alliances are among the strategies health care companies should consider if they want to remain competitive.	2008 industry outlook Get Deloitte's perspectives on what may be ahead for Life Sciences in the areas of cost control, wellness and prevention and talent management.
Improving operational performance Learn how life sciences companies can leverage supply chain management to drive value and mitigate risk.	Challenge and opportunity Lured by China’s stunning economic growth, multinational pharmaceutical companies are increasingly drawn to this potent new market.